Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M05BA06	BONVIVA	B	Ibandronic acid - 3mg/3ml	3mg/3ml	Injectable solution	3,144,591 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10⁸ to 3x10⁹ viable units		Injectable powder for suspension+diluent	13,873,850 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10⁸ to 3x10⁹ viable units		Injectable powder for suspension+diluent	L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	921,176,511 L.L
L01FB01	BESPONSA FOR INJECTION	BioTech	Inotuzumab Ozogamicin - 0.9mg	0.9mg	Injectable powder for suspension	L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	27,390,281 L.L
B02BD04	BENEFIX	BioTech	Nonacog alfa (recombinant coagulation factor IX) - 500IU	500IU	Injectable powder for solution+diluent	L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
L01XG01	BORTEZOMIB ACCORD	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB GP PHARM	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB SPC	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	15,743,401 L.L
L01DC01	BLEO-CELL	G	Bleomycin (sulfate) - 15mg	15mg	Injectable powder for solution	3,817,857 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	19,610,153 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	24,934,922 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE GP PHARM	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (100mg)	2.5mg/ml	Injectable powder for concentrate for solution	16,887,989 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	14,098,526 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	28,437,886 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate) - 15U	15U	Injectable lyophilised powder for solution	2,109,833 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORTEZOMIB SHILPA	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	9,902,420 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	L.L

...